Association of Cardiologist Clinic Visits with Cardiovascular Primary Prevention Outcomes Among People with HIV from Underrepresented Racial and Ethnic Groups in the Southern United States
Authors: Durstenfeld Matthew S. , Larry Hill C. , Clare Robert M. , Chiswell Karen , Sanders Gretchen , Gray Shamea , Cooper Linda , Vicini Joseph , Marsolo Keith , Okeke Nwora Lance , Meissner Eric G. , Thomas Kevin L. , Morse Caryn G. , Bloomfield Gerald S. , Pettit April C. , Longenecker Chris T. 
Published: August 2024

Background

People with HIV (PWH) are at elevated risk for atherosclerotic cardiovascular disease (ASCVD). Underrepresented racial and ethnic groups (UREGs) with HIV in the southern U.S. are disproportionately affected, yet whether cardiology specialist care for this at-risk group improves blood pressure and lipid control or prevents cardiovascular events is unknown.

Methods

We evaluated a cohort of PWH from UREGs at elevated ASCVD risk without known cardiovascular disease who received HIV-related care from 2015–2018 at four academic medical centers in the Southern United States with follow up through 2020. Primary outcomes were blood pressure control (<140/90 mmHg) and lipid control (LDL-C ≤ 100 mg/dl) over 2 years and time to first major adverse cardiovascular (MACE) event. Statistical analyses were adjusted for cohort/site and patient factors including HIV measures and comorbidities.

Results

Among 3972 included PWH (median age 47 years old, 32.6% female) without diagnosed cardiovascular disease, 276 (6.9%) had a cardiology clinic visit. Cardiology clinic visits were not significantly associated with subsequent blood pressure control (adjusted OR 0.78, 95% CI 0.49-1.24, p=0.29) or lipid control (adjusted OR 2.25, 95% CI 0.72-7.01, p=0.16). Over a median follow up of 5 years, patients who had a cardiology clinic visit had higher risk of MACE, overall mortality, and falsification endpoints (hospitalization or death from accident/trauma and pneumonia/sepsis) indicating a higher risk group overall, even after adjusting for measured risk factors.

Conclusions

Among UREG PWH at elevated cardiovascular risk, a cardiology clinic visit was not associated with improved cardiovascular risk factors or reduced risk of cardiovascular events. Our study suggests that seeing a cardiologist is not alone sufficient to promote cardiovascular health or prevent cardiovascular events among PWH, but with low confidence given the higher risk among those who had a cardiology visit.

What is known?

People with HIV are at increased cardiovascular risk, and the burden of both cardiovascular disease and HIV are high among people from underrepresented racial and ethnic groups who live in the Southern United States.

Treating people with HIV at elevated cardiovascular risk with statins reduces risk of cardiovascular events.

What the study adds?

Among people with HIV at elevated cardiovascular risk from underrepresented racial and ethnic groups who received care at four academic medical centers in the southern United States, cardiology clinic visits were not associated with better lipid control, blood pressure control, or prevention of cardiovascular events.

People with HIV who attended a cardiology clinic visit had higher risk of cardiovascular events and mortality.